AVROBIO Receives Orphan Drug Designation from the European Commission for AVRRD04, an Investigational Gene Therapy for Cystinosis – Business Wire

CAMBRIDGE, Mass.--(BUSINESS WIRE)--AVROBIO, Inc. (Nasdaq: AVRO), a leading clinical-stage gene therapy company with a mission to free people from a lifetime of genetic disease, today announced that the European Commission (EC) has granted orphan drug designation for AVR-RD-04, the companys investigational gene therapy for the treatment of cystinosis

Read more
Be The Match BioTherapies Announces Expansion of Multi-Year Strategic Alliance with Orchard Therapeutics to Support European Commercial Launch of…

MINNEAPOLIS--(BUSINESS WIRE)--Be The Match BioTherapies, an organization offering solutions for companies developing and commercializing cell and gene therapies, today announced an expansion of their multi-year partnership with Orchard Therapeutics (Nasdaq: ORTX), a global gene therapy leader, to include supply chain services in support of the upcoming commercial launch of Libmeldy (autologous CD34+ cells encoding the ARSA gene), Orchards gene therapy recently approved in Europe for the treatment of early-onset metachromatic leukodystrophy (MLD). Through the expanded partnership, Be The Match BioTherapies will provide comprehensive support across the commercial supply chain for Libmeldy, including support of the onboarding and training of apheresis centers, oversight of the autologous cell collection process and delivery of both harvested cells to the manufacturing site and gene-corrected cells back to the qualified treatment center.

Read more
Stem Cell Therapy Market Analysis, Industry Outlook, Current Trends and Forecast by 2025 – Just Positivity

The business intelligence report on Stem Cell Therapy market offers a comprehensive analysis of the top growth stimulants, prospects, restraints, and limitations that will shape the business dynamics in the coming years. Further, the report divides the industry vertical into several segments and systematically assesses them to unearth the top revenue prospects. Stem Cell Therapy Market will exceed USD 15 billion by 2025; as per a new research report

Read more
How Will Global Stem Cell Banking Market React from 2021 Onwards? The Courier – The Courier

A recent Market Research Report byMarket Research Store, on Stem Cell Banking Market Overview By Trends, Size, Industry Top Manufacturers, Industry Growth Analysis & Forecast Till 2026 Flourishing data has been added to the collection to provide readers with detailed information about market developments, includes detailed market overview, seller scenario, market dimensions, as well as depth SWOT and PESTEL valuation, aside from other internationally approved market evaluation guidelines that play vital roles in growth of spreading information. The report Stem Cell Banking Market 2020-2026, outlines and describes the key factors influencing market growth. It proposes an in-depth study of market heights (revenue), key market segment, market share, specific geographical regions, key market players and trends in vital industries.

Read more